Selection of a Novel Aptamer Against Vitronectin Using Capillary Electrophoresis and Next Generation Sequencing

Breast cancer (BC) results in ≃40,000 deaths each year in the United States and even among survivors treatment of the disease may have devastating consequences, including increased risk for heart disease and cognitive impairment resulting from the toxic effects of chemotherapy. Aptamer-mediated drug...

Full description

Bibliographic Details

Published in:	Molecular Therapy: Nucleic Acids
Main Authors:	Christopher H Stuart, Kathryn R Riley, Olcay Boyacioglu, Denise M Herpai, Waldemar Debinski, Shadi Qasem, Frank C Marini, Christa L. Colyer, William H Gmeiner
Format:	Article
Language:	English
Published:	Elsevier 2016-01-01
Subjects:	aptamer breast cancer SELEX vitronectin
Online Access:	http://www.sciencedirect.com/science/article/pii/S2162253117301117